Urso 120Ml Suspension 250Mg/5Ml

Name: Urso 120Ml Suspension 250Mg/5Ml
Brand: AGP PHARMA
Price: 1489.64

Brand : agp pharma

Rs. 1,489.64

Rs. 1,568.04

|

QUICK DELIVERY

Urso 120Ml Specification

Requires Prescription (YES/NO)

Yes

Generics

Ursodeoxycholic acid

Used For

Gall Stones

How it works

It contains ursodeoxycholic acid. Ursodeoxycholic acid is a bile acid, which may have a protective effect on the liver by reducing the absorption of other potentially toxic bile salts.

Urso 120Ml Usage And Safety

Dosage

Ursodeoxycholic acid

Side Effects

Diarrhoea , itching/pruritus , urticaria (nettle rash) , allergic reactions , nausea/vomiting , sleep disturbance , pain in the stomach area or in the upper right part of the abdomen, under the ribs , severe right-sided upper abdominal pain , severe worsening (decompensation) of liver tissue damage .

Drug Interactions

Colestyramine, colestipol or antacids containing aluminium hydroxide and/or smectite (aluminium oxide), ciclosporin , budesonide , clofibrate , rosuvastatin.

Indication

Ursodeoxycholic acid is indicated in the treatment of primary biliary cirrhosis (PBC) and for the dissolution of radiolucent gallstones in patients with a functioning gall bladder.

When not to Use

Do not take if you are allergic to any medicine containing ursodeoxycholic acid, bile acids or any of the ingredients . You have a bile duct or gall bladder that is swollen, painful or blocked. You have certain types of cholesterol stones or bile pigment stones . Your doctor advises you that you will have your gall bladder removed.

Urso 120Ml Precautions

Precaution

If diarrhoea occurs, the dose must be reduced and in cases of persistent diarrhoea, the therapy should be discontinued.

Urso 120Ml Warnings

Warning 1

During the first 3 months of treatment, liver function parameters ASAT (SGOT), ALAT (SGPT) and ?-GT should be monitored by the physician every 4 weeks, thereafter every 3 months. Apart from allowing for identification of responders and non-responders in patients being treated for primary biliary cirrhosis, this monitoring would also enable early detection of potential hepatic deterioration, particularly in patients with late stage primary biliary cirrhosis.

Warning 2

In order to assess therapeutic progress and for timely detection of any calcification of the gallstones, depending on stone size, the gall bladder should be visualised (oral cholecystography) with overview and occlusion views in standing and supine positions (ultrasound control) 6-10 months after the beginning of treatment.

Warning 3

If the gall bladder cannot be visualised on X-ray images, or in cases of calcified gallstones, impaired contractility of the gall bladder or frequent episodes of biliary colic, Ursodeoxycholic acid should not be used.

Download the Dvago App